Abstract
Cannabis, the substance more commonly known as marijuana, has gained interest in recent years for its potential use as an antiepileptic agent. The two main components of marijuana are delta-9-tetrahydrocannabinol, which has had mixed effects in epilepsy, and cannabidiol, which has shown more consistent anticonvulsant effects. Data supporting the use of marijuana for this purpose are limited, as the majority of clinical trials were conducted before 1990. There are case reports showing promising results; however, the data are inconsistent and cannot be generalized. The legal issues surrounding marijuana in the United States also may limit the use of this substance as an antiepileptic.
| Original language | English |
|---|---|
| Pages | 24-28 |
| Number of pages | 5 |
| Volume | 40 |
| No | 1 |
| Specialist publication | U.S. Pharmacist |
| State | Published - Jan 1 2015 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science
- Pharmacology
- Pharmacy
Cite this
Marijuana for the treatment of seizure disorders. / Knezevich, Emily; Wu, Yunuo.
In: U.S. Pharmacist, Vol. 40, No. 1, 01.01.2015, p. 24-28.Research output: Contribution to specialist publication › Article
}
TY - GEN
T1 - Marijuana for the treatment of seizure disorders
AU - Knezevich, Emily
AU - Wu, Yunuo
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Cannabis, the substance more commonly known as marijuana, has gained interest in recent years for its potential use as an antiepileptic agent. The two main components of marijuana are delta-9-tetrahydrocannabinol, which has had mixed effects in epilepsy, and cannabidiol, which has shown more consistent anticonvulsant effects. Data supporting the use of marijuana for this purpose are limited, as the majority of clinical trials were conducted before 1990. There are case reports showing promising results; however, the data are inconsistent and cannot be generalized. The legal issues surrounding marijuana in the United States also may limit the use of this substance as an antiepileptic.
AB - Cannabis, the substance more commonly known as marijuana, has gained interest in recent years for its potential use as an antiepileptic agent. The two main components of marijuana are delta-9-tetrahydrocannabinol, which has had mixed effects in epilepsy, and cannabidiol, which has shown more consistent anticonvulsant effects. Data supporting the use of marijuana for this purpose are limited, as the majority of clinical trials were conducted before 1990. There are case reports showing promising results; however, the data are inconsistent and cannot be generalized. The legal issues surrounding marijuana in the United States also may limit the use of this substance as an antiepileptic.
UR - http://www.scopus.com/inward/record.url?scp=84921881882&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921881882&partnerID=8YFLogxK
M3 - Article
VL - 40
SP - 24
EP - 28
JO - U.S. Pharmacist
JF - U.S. Pharmacist
SN - 0148-4818
ER -